Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide patients and their physicians with greater
understanding of the risks and benefits of commonly used therapies for treatment of non-CF
bronchiectasis
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
COPD Foundation National Jewish Health Patient-Centered Outcomes Research Institute University of Alabama at Birmingham